Boston Scientific ($BSX) announced simultaneous approval to market its AngioJet ZelanteDVT thrombectomy catheter for treating deep vein thrombosis in the U.S., Europe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback